產(chǎn)品資料
產(chǎn)品[

CRL-2265 CEM/C1 人急性**細(xì)胞白血病細(xì)胞

]資料
如果您對(duì)該產(chǎn)品感興趣的話,可以 sendmsg
產(chǎn)品名稱: CRL-2265 CEM/C1 人急性**細(xì)胞白血病細(xì)胞
產(chǎn)品型號(hào): CRL-2265
產(chǎn)品廠商: 美國(guó)標(biāo)準(zhǔn)生物品收藏中心(ATCC)
產(chǎn)品文檔: 無相關(guān)文檔


簡(jiǎn)單介紹

CRL-2265 CEM/C1 人急性**細(xì)胞白血病細(xì)胞, ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞;細(xì)胞庫(kù)管理規(guī)范,提供的細(xì)胞株背景清楚,提供參考文獻(xiàn)和培養(yǎng)條件!


CRL-2265 CEM/C1 人急性**細(xì)胞白血病細(xì)胞 的詳細(xì)介紹
CRL-2265 CEM/C1 人急性**細(xì)胞白血病細(xì)胞
ATCC® Number: CRL-2265? Price:  
Designations: CEM/C1
Depositors: WG Harker
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension
Organism: Homo sapiens
Morphology: lymphoblast

Source: Organ: peripheral blood
Disease: acute lymphoblastic leukemia
Cell Type: T lymphoblast;
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: 4 years
Gender: female
Ethnicity: Caucasian
Comments: CEM/C1 is a camptothecin (CPT) resistant derivative of the human T cell leukemia cell line CCRF-CEM (see ATCC CCL-119).
The cell line was selected and subcloned in 1991 for resistance to CPT.
The cells exhibit cross resistance to both the water soluble (topotecan) and water insoluble (9-amino-CPT and 10,11-methylenedioxy-CPT) analogs of CPT.
CEM/C1 cells are approximately 31 fold less sensitive to CPT than the parental CEM cells.
CEM/C1 cells display atypical multidrug resistance (MDR) and altered topoisomerase I catalytic activity.
Resistance to CPT is stable for up to six months.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of medium. Establish new cultures at 2 X 10 exp5 viable cells/ml and maintain between 1 X 10 exp5 and 2 X 10 exp6.
Preservation: culture medium 95%; DMSO, 5%
Doubling Time: 26 hrs
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
parental cell line:ATCC CCL-119
References: 22339: Kapoor R, et al. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin. Oncol. Res. 7: 83-95, 1995. PubMed: 7579731
23117: Fujimori A, et al. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res. 55: 1339-1346, 1995. PubMed: 7882333
產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!

聯(lián)系我們
產(chǎn)品搜索

細(xì)胞系,ATCC細(xì)胞,ATCC菌種,細(xì)胞系目錄,ATCC,鼠傷寒沙門氏菌,atcc細(xì)胞庫(kù),人**瘤細(xì)胞,人食管癌細(xì)胞,ATCC 19404,ATCC 25922,ATCC 19146,微生物菌種,細(xì)胞株,標(biāo)準(zhǔn)菌株,ATCC中國(guó),atcc上海代理,CMCC 菌株,ATCC菌株,細(xì)胞目錄,質(zhì)控菌株,腫瘤細(xì)胞株,乳腺癌細(xì)胞系,人肝癌細(xì)胞系

產(chǎn)品目錄

Copyright? 2003-2025  上海復(fù)祥生物科技有限公司版權(quán)所有            電話:021-35080510
傳真:021-35080520    地址:上海市虹口區(qū)赤峰路630號(hào)南雁大廈1901室    郵編: 滬ICP備10013034號(hào)-3  

  

滬公網(wǎng)安備 31010902002429號(hào)